Likewise, PKCβ was found to play a critical role as a modulator of hepatocellular carcinoma cell motility and invasion through the activation of the ERK1/2/p38MAPK-HSP27 pathway [137]. Here, PRKCB is linked to hepatocellular carcinoma.